Shareholders Shanghai Tan Ying and Shanghai Tan Zheng of JUNSHI BIO (01877) have collectively reduced their holdings by approximately 739.27 million shares of A shares. The reduction plan has been fully implemented.

21:04 12/11/2024

Kunshen Biotechnology (01877) announced that the company received a notification from Shanghai Tanying on November 12, 2024...

JUNSHI BIO (01877) announced that on November 12, 2024, the company received a notice from Shanghai Tan Ying and Shanghai Tan Zheng regarding the completion of their reduction plan and the results of the reduction of shares. From October 23, 2024 to November 12, 2024, Shanghai Tan Ying and Shanghai Tan Zheng collectively reduced 7,392,674 A-shares of the company through centralized bidding, accounting for 0.75% of the company's total share capital. As of November 12, 2024, the reduction plan has been successfully implemented.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families